本页面由Tiger Trade Technology Pte. Ltd.提供服务

Assembly Biosciences Inc.

20.34
-2.4300-10.67%
盘后:20.430.0900+0.44%16:55 EDT
成交量:30.56万
成交额:640.58万
市值:4.14亿
市盈率:-7,923.65
高:22.64
开:22.64
低:20.28
收:22.77
52周最高:39.71
52周最低:20.28
股本:2,036.06万
流通股本:917.37万
量比:1.27
换手率:3.33%
股息:- -
股息率:- -
每股收益(TTM):-0.0026
每股收益(LYR):-0.5461
净资产收益率:-0.03%
总资产收益率:-2.67%
市净率:1.35
市盈率(LYR):-37.25

数据加载中...

2023/11/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/10/17

重要事件披露

Form 8-K - Current report
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities